A. Koreen

发表

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.

J. Lieberman, J. Kane, M. Chakos, 1995, The American journal of psychiatry.

Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

J. Lieberman, R. Bilder, D. Robinson, 1999, The American journal of psychiatry.

Incidence and correlates of acute extrapyramidal symptoms in first episode schizophrenia

J. Lieberman, B. Sheitman, M. Chakos, 1995, Schizophrenia Research.

Incidence and Correlates of Tardive Dyskinesia in First Episode of Schizophrenia

J. Lieberman, M. Borenstein, J. Kane, 1996 .

Cross-tapering clozapine and risperidone.

J. Lieberman, T. Cooper, A. Koreen, 1995, The American journal of psychiatry.

Treatment of neuroleptic-resistant schizophrenic relapse.

P. Weiden, J. Kane, B. Kinon, 1993, Psychopharmacology bulletin.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

J. Lieberman, R. Bilder, D. Robinson, 1999, Archives of general psychiatry.

Biological predictors of antipsychotic treatment response

J. Lieberman, B. Sheitman, A. Koreen, 1996 .

Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.

J. Lieberman, M. Chakos, F. Amin, 1994, Archives of general psychiatry.

Neurochemistry and neuroendocrinology of schizophrenia: a selective review.

J. Lieberman, A. Koreen, Jeffrey A. Ueberman, 1993, Schizophrenia bulletin.

Dr. Robinson and Colleagues Reply

J. Lieberman, D. Robinson, M. Chakos, 1995 .

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.

J. Lieberman, J. Kane, B. Sheitman, 1995, The American journal of psychiatry.

Psychobiologic Correlates of Treatment Response in Schizophrenia

J. Lieberman, B. Sheitman, M. Chakos, 1996, Neuropsychopharmacology.

Reduced caudate nucleus volume in obsessive-compulsive disorder.

M Ashtari, B. Bogerts, M. Ashtari, 1995, Archives of general psychiatry.

The Behavioral Effect of m-Chlorophenylpiperazine (mCPP) and Methylphenidate in First-Episode Schizophrenia and Normal Controls

J. Lieberman, M. Chakos, J. Alvir, 1995, Neuropsychopharmacology.

Diagnostic stability in patients followed from their first episode of schizophrenia or schizoaffective disorder

J. Lieberman, D. Robinson, M. Woerner, 1995, Schizophrenia Research.

Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.

J. Lieberman, R. Bilder, B. Sheitman, 1996, The Journal of clinical psychiatry.

Depression in first-episode schizophrenia.

J. Lieberman, M. Chakos, S. Siris, 1993, The American journal of psychiatry.

Incidence and correlates of tardive dyskinesia in first episode schizophrenia

J. Lieberman, R. Bilder, M. Chakos, 1995, Schizophrenia Research.

Time to treatment response in successive episodes of early onset schizophrenia

J. Lieberman, M. Chakos, A. Loebel, 1995, Schizophrenia Research.

Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital.

J. Lieberman, D. Levy, B. Bogerts, 1992, Schizophrenia bulletin.

Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.

J. Lieberman, J. Kane, M. Chakos, 1994, The American journal of psychiatry.